Ann-Tove Kongsnes

Ann-Tove Kongsnes currently works at Investinor AS, as Deputy CEO & Chief Investment Officer from 2021, Numascale AS, as Director, St. Olavs Hospital HF, as Deputy Director, SpinChip Diagnostics AS, as Director, Vitux Group AS, as Director, EXACT Therapeutics AS, as Director, Data-Consult AS, as Deputy Director, Orientekspressen AS, as Deputy Director, and Shelterwood AS, as Director.
Ms. Kongsnes also formerly worked at Ayanda AS, as Vice Chairman, poLight ASA, as Deputy Chairman, The National Security Group, Inc., as Director-Operations & Marketing, Calliditas Therapeutics AB, as Independent Non-Executive Director from 2013 to 2019, NTNU Technology Transfer AS, as Director, Sana Pharma Medical AS, as Director, BerGenBio ASA, as Deputy Director, Soundrop AS, as Deputy Director, Nordic Halibut AS, as Director, Curida AS, as Director, Proventure Management AS, as Investment Manager, Norges Sjømatråd AS, as Marketing Manager, and Leiv Eiriksson Nyskaping AS, as Manager-Business Development.
Ms. Kongsnes received her undergraduate degree from Norwegian School of Economics & Business Administration and Masters Business Admin degree in 1993 from Bodo University College.